Literature DB >> 33488921

Unilateral Linear Induration of the Skin: A Case Report of an Unusual Presentation of Scleredema.

Jihan Muhaidat1, Firas Al-Qarqaz1, Diala Alshiyab1.   

Abstract

Scleredema is an idiopathic condition with specific clincopathological findings, including symmetrical and diffuse nonpitting induration of the upper body and thickened dermis due to deposition of acid mucopolysaccharides. Here, we report a case of linear scleredema in a healthy female patient, who presented with firm induration of the skin over her right shoulder and arm in a Blaschkolinear distribution. The onset was insidious in childhood and stable over several years. While the clinical picture has closely mimicked linear morphea, the diagnosis of scleredema was confirmed by the typical histopathological findings. To the best of our knowledge, linear scleredema is a unique presentation that has not been previously reported.
Copyright © 2020. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Blaschko’s lines; Scleredema; linear

Year:  2020        PMID: 33488921      PMCID: PMC7819589     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  17 in total

1.  Scleredema of Buschke with prominent periorbital edema.

Authors:  Luca Fania; Laura Colonna; Gianluca Pagnanelli; Damiano Abeni; Giorgio Annessi; Cinzia Mazzanti
Journal:  Int J Dermatol       Date:  2017-05-02       Impact factor: 2.736

2.  Neck Pain, Stiffness, and Periorbital Edema in a Man With Diabetes.

Authors:  Soumya Chatterjee
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

3.  Scleredema adultorum. Not always a benign self-limited disease.

Authors:  A C Curtis; B M Shulak
Journal:  Arch Dermatol       Date:  1965-11

4.  European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Authors:  R Knobler; P Moinzadeh; N Hunzelmann; A Kreuter; A Cozzio; L Mouthon; M Cutolo; F Rongioletti; C P Denton; L Rudnicka; L A Frasin; V Smith; A Gabrielli; E Aberer; M Bagot; G Bali; J Bouaziz; A Braae Olesen; I Foeldvari; C Frances; A Jalili; U Just; V Kähäri; S Kárpáti; K Kofoed; D Krasowska; M Olszewska; C Orteu; J Panelius; A Parodi; A Petit; P Quaglino; A Ranki; J M Sanchez Schmidt; J Seneschal; A Skrok; M Sticherling; C Sunderkötter; A Taieb; A Tanew; P Wolf; M Worm; N J Wutte; T Krieg
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-08       Impact factor: 6.166

5.  Scleredema adultorum of buschke associated with non-scarring alopecia of scalp.

Authors:  A Singal; V Gandhi; S N Bhattacharya; G Khanna; M C Baruah
Journal:  Indian J Dermatol Venereol Leprol       Date:  1999 Jan-Feb       Impact factor: 2.545

6.  Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.

Authors:  Elaine Kunzler; Stephanie Florez-Pollack; Noelle Teske; Jack O'Brien; Smriti Prasad; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2019-04-17       Impact factor: 11.527

7.  Scleredema adultorum of Buschke presenting as periorbital edema: a diagnostic challenge.

Authors:  Despina I Ioannidou; Konstantin Krasagakis; Maria P Stefanidou; Spyros Karampekios; John Panayiotidis; Androniki D Tosca
Journal:  J Am Acad Dermatol       Date:  2005-02       Impact factor: 11.527

8.  Atypical Scleredema Involving the Hands in an Adolescent.

Authors:  Caroline M Lewis; April T Sanchez; Loretta S Davis
Journal:  Pediatr Dermatol       Date:  2016-08-30       Impact factor: 1.588

9.  Scleredema: a review of thirty-three cases.

Authors:  P Y Venencie; F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1984-07       Impact factor: 11.527

10.  [Systemic Buschke's scleredema with cardiomyopathy, monoclonal IgG kappa gammopathy and amyloidosis. Case report with autopsy].

Authors:  R A Paz; R E Badra; H M Martí; M J Maxit
Journal:  Medicina (B Aires)       Date:  1998       Impact factor: 0.653

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.